Publication | Closed Access

Quinazoline clubbed 1,3,5-triazine derivatives as VEGFR2 kinase inhibitors: design, synthesis, docking, in vitro cytotoxicity and in ovo antiangiogenic activity

Vegfr2 Kinase InhibitorsMedicinal ChemistryMedicineOvo Antiangiogenic Activity1,3,5-Triazine DerivativesPharmacological AgentPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyNovel TherapyDrug Discovery